Introduction
For individuals at ongoing risk of HIV exposure, prevention plays an important role in long-term health and peace of mind. While daily oral PrEP medications have helped many people reduce their risk of HIV infection, some individuals may prefer alternatives that do not require taking a pill every day. Apretude was developed to provide a long-acting injectable option for HIV prevention.
Apretude is FDA-approved as pre-exposure prophylaxis (PrEP) for adults and adolescents who are HIV-negative and at risk of sexually acquired HIV-1 infection. The medication is given as a scheduled injection by a healthcare professional and is designed to remain active in the body for an extended period of time.
Unlike daily oral PrEP therapies, Apretude provides long-acting HIV prevention through maintenance injections typically administered every two months after the initial dosing phase. For some patients, this may offer greater convenience and reduce the burden of remembering daily medication.
Apretude works by blocking HIV integrase, an enzyme the virus needs to replicate and establish infection within the body. When administered as directed, the medication has been shown in clinical studies to significantly reduce the risk of sexually acquired HIV-1 infection.
Although Apretude may provide important prevention benefits, specialty injectable medications can also create financial concerns. Costs related to healthcare administration, specialty pharmacy coordination, ongoing HIV testing, and treatment visits may become difficult to manage without insurance coverage or financial assistance programs.
Prescription Hope works with individuals searching for ways to make medications more affordable. Through patient assistance programs and medication advocacy support, Prescription Hope helps eligible patients navigate the enrollment process for medications like Apretude. After approval, patients with Prescription Hope enjoy continued service with refill scheduling, document updates, program monitoring, yearly renewals, and more.
Understanding how Apretude works, potential side effects, treatment benefits, and available medication access resources can help individuals make informed decisions when discussing HIV prevention options with their healthcare provider.
What Is the Apretude Patient Assistance Program?
Unfortunately, many medications dedicated to helping treat or manage HIV are expensive and difficult to afford for those who struggle financially. This means HIV prevention medication assistance is a growing search trend among at-risk populations.
Pharmaceutical manufacturers understand that not all of their products are affordable for the average American. Thankfully, many provide a solution.
When a brand-name medication comes to market, some manufacturers will launch Patient Assistance Programs. These offer the brand-name medication at an affordable rate to those who qualify.
Typically, qualification depends on factors such as income, insurance level, prescription status, and residency.
However, there is a catch.
Patient assistance programs can be known for being complex and difficult to apply for. This means added stress and frustration for patients who are dealing with the burden of treatment and financial costs related to their medication.
Prescription Hope provides a way forward.
How Expert Advocates Help Make Apretude More Affordable
Professional Application Management
Prescription Hope offers professional application management for those looking to enroll in patient assistance programs.
We complete all required forms, collect necessary documentation, coordinate signatures with healthcare providers, and communicate with the manufacturer as needed.
Our team of Florida-based patient advocates works hard to be your patient advocate through your medication access journey.
Apretude Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Predictable Monthly Pricing
While plenty of savings options exist, Prescription Hope is different from the rest.
We are not a discount card, coupon, insurance company, or affiliated with any government program. Instead, we offer a full medication access management service for qualified patients. This means we continue to take care of your program access, so you don’t have to.
All for $70.00 per med, per month. No hassles, hidden surprises, or medication costs.
Plus, if you do not qualify for the Apretude Patient Assistance Program, we’ll work to help you find another way to save. Whether it’s a substitute medication and its program, discount card, or coupon, we’ll try to find you access to more affordable medication costs.
And if we can’t help you save, then you don’t pay anything.
Ongoing Advocacy and Refill Support
Not only does Prescription Hope help you find Apretude cost assistance, but our service goes beyond the HIV PrEP financial assistance solutions you’ve been looking for.
We continue to coordinate with the manufacturer and take care of things like refill scheduling, document updates, yearly renewals, and more.
Apretude Patient Assistance Eligibility
Wanting PrEP medication support, but wondering about your HIV prevention assistance eligibility?
Prescription Hope may be able to help you access the Apretude Patient Assistance Program. However, to qualify, patients must meet certain criteria. While each program is different, the criteria typically fall into several general categories. Some of those categories include:
Income: Requirements include specific income thresholds. These criteria vary by program.
Insurance coverage: Every program has its own requirements regarding insurance coverage status.
Prescription: Patients who apply must have a valid prescription for the brand-name medication they wish to apply for.
U.S. resident: Each applicant must be a valid U.S. resident.
Simple Enrollment With Expert Support
Starting Your Journey
Ready to enroll in Apretude assistance through Prescription Hope?
To get started on applying for the Apretude Patient Assistance Program through Prescription Hope, you only need to follow 6 simple steps:
- Submit Information: Complete our online enrollment form.
- Advocate Contact: After we receive your form, a patient advocate will reach out within 1-2 business days.
- Document Collection: After you’re prequalified, we’ll collect all necessary documents.
- Provider Coordination: Our team will coordinate with your healthcare provider to procure all signatures required by the manufacturer.
- Program Submission: Once your application packet is in order, we’ll submit it and continue to follow up throughout your application process.
- Medication Delivery: After approval, patients typically see their medication shipped directly to their door or doctor’s office within 2 weeks.
Please note that Prescription Hope is not a pharmacy, healthcare provider, or manufacturer. Therefore, we do not, at any time, handle medication. Medication ships directly from the manufacturer to you or your healthcare provider.
Medication Delivery and Ongoing Support
After initial delivery, we continue to advocate on your behalf. We manage refill scheduling, take care of document updates, monitor your program for any changes, and handle your yearly renewals.
Understanding Apretude
How Apretude Works
Apretude works by blocking HIV integrase, an enzyme the virus needs to replicate and spread within the body. By interfering with this process, the medication helps prevent HIV from establishing an infection in human cells after exposure.
The medication contains cabotegravir, which is classified as an integrase strand transfer inhibitor (INSTI). When administered as directed, Apretude helps reduce the risk of sexually acquired HIV-1 infection in individuals who are HIV-negative before starting treatment.
One of the key features of Apretude is its long-acting formulation. Instead of requiring daily oral dosing, the medication remains active in the body for an extended period of time, allowing for scheduled injectable treatment administered by a healthcare professional.
Most patients receive initial injections one month apart, followed by maintenance injections every two months. Some individuals may begin treatment with an optional oral lead-in period using oral cabotegravir to evaluate tolerability before starting injections.
Because HIV prevention effectiveness depends on maintaining adequate medication levels, ongoing treatment adherence, and regular HIV testing are important throughout therapy.
What Conditions Does Apretude Treat?
Apretude is FDA-approved for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds).
The medication is intended for individuals who are confirmed HIV-negative prior to starting treatment. HIV testing is required before initiating therapy and before each scheduled injection to reduce the risk of developing drug-resistant HIV strains.
Apretude may be considered for individuals seeking an alternative to daily oral PrEP medications. Some patients may prefer injectable HIV prevention because it reduces the need for daily pill adherence and provides a more discreet prevention option.
Healthcare providers evaluate individual HIV exposure risk, medical history, medication interactions, and lifestyle considerations when determining whether Apretude is an appropriate HIV prevention strategy.
Benefits of Treatment
For many individuals at ongoing risk of HIV exposure, Apretude may provide several important prevention and convenience benefits.
Potential benefits of Apretude treatment may include:
- Long-acting HIV prevention with fewer doses per year
- Reduced the need for daily oral medication adherence
- Effective HIV prevention when administered as directed
- Greater convenience for some individuals compared to daily PrEP tablets
- Discreet injectable HIV prevention option
- Expanded prevention choices for individuals seeking alternatives to daily oral medications
Clinical studies demonstrated that Apretude significantly reduced the risk of sexually acquired HIV-1 infection when administered according to the recommended treatment schedule.
Treatment effectiveness depends on maintaining scheduled injections and ongoing HIV testing throughout therapy. Patients should continue regular follow-up care with their healthcare provider to help ensure safe and effective HIV prevention.
Important Safety Information and Side Effects
Apretude carries important safety considerations and an FDA boxed warning regarding the risk of drug resistance in individuals with undiagnosed HIV-1 infection.
Before starting treatment and before each scheduled injection, patients must undergo HIV-1 testing to confirm they remain HIV-negative. Use of Apretude in individuals with undiagnosed HIV infection may increase the risk of developing drug-resistant HIV strains.
Patients should not miss scheduled injections without discussing alternative HIV prevention options with their healthcare provider. Because the medication remains in the body for an extended period after stopping treatment, follow-up care is important if therapy is discontinued.
Common side effects associated with Apretude may include:
- Injection site pain or swelling
- Fever
- Fatigue
- Headache
- Muscle pain
- Rash
- Nausea
- Dizziness
- Sleep disturbances
Injection site reactions are among the most commonly reported side effects and are generally related to the administration of the medication.
Serious hypersensitivity or allergic reactions may occur in some patients. Individuals should seek medical attention if they experience symptoms such as severe rash, swelling, difficulty breathing, or severe dizziness.
Liver problems have also been reported during treatment. Patients should contact their healthcare provider if they develop symptoms such as yellowing of the skin or eyes, dark urine, abdominal pain, or persistent nausea.
Some individuals may experience depression or mood changes during treatment. Patients should discuss any mental health concerns or worsening mood symptoms with their healthcare provider.
Apretude should not be used in individuals with positive or unknown HIV-1 status, prior hypersensitivity to cabotegravir, or certain medication interactions involving drugs such as some anticonvulsants and rifamycin antibiotics.
Patients should discuss pregnancy, breastfeeding, current medications, and supplements with their healthcare provider before beginning treatment.
Access to Multiple Medications
We offer access to specialty medication assistance and HIV prevention medication support to those who qualify.
However, that’s not all we do.
We work with hundreds of brand-name medications daily. This means that if you qualify for several brand-name medications on our availability list, then we can help.
Whether you qualify for one or many, Prescription Hope’s predictable service rate continues at $70.00 per month, per medication.
Why Choose Prescription Hope for Apretude Assistance
Experienced Advocacy Support
For two decades, Prescription Hope has led in medication access service. Our patients live across America and often save hundreds, if not thousands, on their medication costs every month.
Ongoing Medication Management
We don’t just help you apply for the Apretude Patient Assistance Program. We continue to advocate on your behalf, handling refill scheduling, document updates, yearly renewals, and more.
Transparent Monthly Pricing
Our price is a predictable and transparent $70.00 per month, per medication. No hassles, surprises, or hidden tricks.
Nationwide Medication Access Support
After 20 years, we’ve built a network that has included hundreds of pharmaceutical manufacturers and tens of thousands of healthcare providers.
So, if you’re looking for affordable Apretude assistance and are interested in accessing the Apretude Patient Assistance Program through Prescription Hope, then be sure to enroll with us by completing our online enrollment form today!
